« Return to News | CROs/Service Providers

Cromsource acquires PDR Partners, expands U.K. staffing solutions services

Friday, October 12, 2012 11:33 AM

Cromsource, a global full-service CRO, has acquired of PDR Partners, a staffing and recruitment organization supporting biopharmaceutical and medical device companies, with offices in Bracknell, U.K.

“For some time we have wanted to expand our staffing solutions business to further support our clients in the U.K. with their staffing needs,” said Oriana Zerbini, CEO of Cromsource. “The opportunity to achieve this through the addition of the experienced and successful team from PDR Partners is of great importance to us. With this exciting collaboration Cromsource reinforces its capability to support its clients with a full-service portfolio across both Europe and the U.S.”

“We are very excited to be joining the Cromsource family and working together to provide exceptional services to our current and future clients,” said Claire Jackaman, managing director of PDR Partners. “With Cromsource we share a philosophy of quality, flexibility and intense customer focus and we look forward to an exciting future together.”

Jackaman will remain in charge of Cromsource’s staffing solutions in the UK.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.